We are live on ! Find out more
NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $121M
1-Year Est. Return 56.89%
This Fund
S&P 500
This Quarter Est. Return
+48.34%
1 Year Est. Return
+56.89%
3 Year Est. Return
+244.35%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$161M
AUM Growth
+$37.1M
Cap. Flow
-$4.8M
Cap. Flow %
-2.99%
Top 10 Hldgs %
82.84%
Holding
41
New
2
Increased
4
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$2.91M
2
ALPN
Alpine Immune Sciences Inc
ALPN
+$1.13M
3
PACB icon
Pacific Biosciences
PACB
+$1.13M
4
KALV
KalVista Pharmaceuticals
KALV
+$634K
5
GERN icon
Geron
GERN
+$311K

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$9.99M
2
OCS icon
Oculis Holding
OCS
+$911K
3
AKRO
Akero Therapeutics
AKRO
+$224K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMEA icon
26
Biomea Fusion
BMEA
$91.3M
$581K 0.36%
40,000
– –
ARGX icon
27
argenx
ARGX
$54.1B
$544K 0.34%
1,430
– –
LONA
28
LeonaBio Inc
LONA
$72.1M
$437K 0.27%
18,000
– –
EAR
29
DELISTED
Eargo, Inc. Common Stock
EAR
$383K 0.24%
147,904
– –
DBVT
30
DBV Technologies
DBVT
$847M
$353K 0.22%
37,095
– –
BMRN icon
31
BioMarin Pharmaceuticals
BMRN
$12.4B
$349K 0.22%
3,615
– –
MDGL icon
32
Madrigal Pharmaceuticals
MDGL
$11.8B
$273K 0.17%
+1,182
New +$207K
AFMD
33
DELISTED
Affimed
AFMD
$233K 0.15%
37,247
– –
BCRX icon
34
BioCryst Pharmaceuticals
BCRX
$2.4B
$107K 0.07%
17,847
– –
GRTX
35
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$89.2K 0.06%
613,223
– –
ABCL icon
36
AbCellera Biologics
ABCL
$2.12B
$71.5K 0.04%
12,521
– –
KOD icon
37
Kodiak Sciences
KOD
$2.84B
$59.7K 0.04%
19,622
– –
KYNB
38
Kyntra Bio
KYNB
$29.4M
$55K 0.03%
2,484
– –
CERS icon
39
Cerus
CERS
$474M
$30.6K 0.02%
14,172
– –
AKRO
40
DELISTED
Akero Therapeutics
AKRO
– –
-4,425
Closed -$224K
SGEN
41
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-47,096
Closed -$9.99M
1
2

Similar funds

MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
CCM
Candelo Capital Management New York $121M AUM 113.39% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
MW
Merited Wealth North Bay Village, Florida $121M AUM

Nan Fung Group Holdings's Q4 2023 Portfolio in Review

As of Q4 2023, Nan Fung Group Holdings held 41 positions worth $161M, up 30% from $123M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Nan Fung Group Holdings's Q4 2023 filing shows 2 new, 4 increased, 1 reduced and 2 closed positions. Its largest new stake was Mirum Pharmaceuticals: 96,100 shares worth $2.84M. The largest sale was Seagen Inc. Common Stock, an estimated $9.99M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Nan Fung Group Holdings's largest Q4 2023 buy was Mirum Pharmaceuticals: 96,100 shares worth $2.84M.
  • Nan Fung Group Holdings added most to Alpine Immune Sciences Inc in Q4 2023, an estimated $1.13M increase.
  • Nan Fung Group Holdings's biggest Q4 2023 reduction was Oculis Holding, cutting an estimated $911K.
  • Nan Fung Group Holdings fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $9.99M.
  • Nan Fung Group Holdings's ten largest holdings make up 83% of its $161M portfolio in Q4 2023.
  • Nan Fung Group Holdings opened 2 new positions and closed 2 in Q4 2023.
  • Nan Fung Group Holdings's portfolio value rose 30% quarter-over-quarter to $161M.

Based on Nan Fung Group Holdings's 13F filing for Q4 2023, filed 13 Feb 2024.